University of Florida launches unique translational biotechnology master’s program
The program is especially timely because biotechnology is poised as an important economic engine that will power growth for the state of Florida.
In addition to curricular and practical training in biomedical and laboratory science, students will receive intensive training in business administration. Graduates will earn a Master of Science degree in medical sciences, with a minor in business administration.
“They are going to really understand the science fundamentals, how products are developed, how business functions, what the main drivers of project management are, how projects and resources are budgeted, the types of timelines involved and the different kinds of expertise needed to develop new therapeutic products,” said molecular genetics and microbiology associate professor Richard Snyder, Ph.D., the program director and director of Biotherapeutic Programs in the UF Office of Research.
Students entering the program typically have a strong background in chemistry and biology and will learn how to conduct advanced applied research. By the time they graduate from the program, they will also have a strong grounding in business management. The program presents additional career and re-training options in a high-skill, high-wage industry for many individuals, including traditional students and people who are underemployed or have been displaced.
The two-year, thesis-optional program is research-intensive and includes a formal internship at a Florida biotechnology company. Industry leaders serve on the program’s advisory board.
Most read news
Other news from the department career
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.